Trials / Unknown
UnknownNCT02822053
Effectivity and Safety of Ultrasound-guided Percutaneously Laser Ablation for Refractory Neoplasms
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- First Affiliated Hospital of Zhejiang University · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and efficacy of ultrasonography (US) -guided laser ablation liver, kidney, pancreas, lung and retroperitoneal tumors, the investigators used preoperative and postoperative US/CEUS/CT/MRI to assess lesions, and laboratory tests including the tumor markers to evaluate the general condition of patients. Intraoperative US/CEUS/CT would be applied to monitor ablation lesions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | US-guided laser ablation for refractory neoplasms |
Timeline
- Start date
- 2016-04-01
- Primary completion
- 2018-06-01
- Completion
- 2018-06-01
- First posted
- 2016-07-04
- Last updated
- 2016-07-04
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02822053. Inclusion in this directory is not an endorsement.